Revance Therapeutics Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell

20

RVNC
Revance Therapeutics

Last Price:

5.82

Seasonality Move:

-10.6%

Sell

19

APLS
Apellis Pharmaceuticals

Last Price:

32.49

Seasonality Move:

18.8%

Sell

20

Revance Therapeutics (RVNC) is a Sell

Is Revance Therapeutics a Buy, Sell or Hold?

The current Revance Therapeutics [RVNC] share price is $5.81. The Score for RVNC is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
RVNC is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

Sell

19

Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

RVNC Stock Price Chart

What is Revance Therapeutics's stock price today?

The Revance Therapeutics share price today is $5.81
The current trend is moderately bearish and RVNC is experiencing slight selling pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

The Apellis Pharmaceuticals share price today is $32.50
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

RVNC Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.15	Buy
Relative Strength Index (14 RSI):	43.04	Sell
Chaikin Money Flow:	-820630	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(6.18 - 6.72)	Sell
Bollinger Bands (100):	(2.61 - 5.71)	Buy

APLS Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.84	Sell
Relative Strength Index (14 RSI):	33.6	Sell
Chaikin Money Flow:	-1084788	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(36.37 - 40.01)	Sell
Bollinger Bands (100):	(36.55 - 42.35)	Sell

RVNC Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	6.16	Sell
20-day SMA:	6.41	Sell
50-day SMA:	5.27	Buy
200-day SMA:	5.03	Buy
8-day EMA:	6.08	Sell
20-day EMA:	6.14	Sell
50-day EMA:	5.45	Buy
200-day EMA:	6.57	Sell

APLS Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	36.19	Sell
20-day SMA:	38.04	Sell
50-day SMA:	37.88	Sell
200-day SMA:	50	Sell
8-day EMA:	35.96	Sell
20-day EMA:	37.21	Sell
50-day EMA:	38.25	Sell
200-day EMA:	45.7	Sell

Revance Therapeutics Earnings Growth & RVNC Earnings Dates

Analysts estimate an earnings increase this quarter of $0.54 per share, an increase next quarter of $0.40 per share, an increase this year of $2.64 per share, and an increase next year of $0.70 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Revance Therapeutics Technical Analysis

	Sep 9	Sep 10	Sep 11	Sep 12	Sep 13	Sep 16	Sep 17	Sep 18	Sep 19	Sep 20
	Sep
	09	10	11	12	13	16	17	18	19	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

	Sep 9	Sep 10	Sep 11	Sep 12	Sep 13	Sep 16	Sep 17	Sep 18	Sep 19	Sep 20
	Sep
	09	10	11	12	13	16	17	18	19	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):